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Abstract
Variant Creutzfeldt-Jakob disease and scrapie are typically initiated by extracerebral exposure to prions,
and exhibit early prion accumulation in germinal centers. Follicular dendritic cells (FDCs), whose
development and maintenance in germinal centers depends on tumor necrosis factor (TNF) and
lymphotoxin (LT) signaling, are thought to be indispensable for extraneural prion pathogenesis. Here,
we administered prions intraperitoneally to mice deficient for TNF and LT signaling components. LT
alpha(-/-), LT beta(-/-), LT betaR(-/-), and LT alpha(-/-) x TNFalpha(-/-) mice resisted infection and
contained no infectivity in spleens and lymph nodes (when present). However, TNFR1(-/-), TNFR2(-/-),
and some TNFalpha(-/-) mice developed scrapie similarly to wild-type mice. High prion titers were
detected in lymph nodes, but not spleens, of TNFR1(-/-) and TNF alpha(-/-) mice despite absence of
FDCs and germinal centers. Transfer of TNFR1(-/-) fetal liver cells into lethally irradiated Prnp(0/0)
mice restored infectivity mainly in lymph nodes. Prion protein (PrP) colocalized with a minority of
macrophages in tumor necrosis factor receptor (TNFR) 1(-/-) lymph nodes. Therefore, prion
pathogenesis can be restricted to lymphoreticular subcompartments, and mature follicular dendritic cells
are dispensable for this process. Macrophage subsets are plausible candidates for lymphoreticular prion
pathogenesis and neuroinvasion in the absence of FDCs, and may represent a novel target for
postexposure prophylaxis.
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Variant Creutzfeldt–Jakob disease and scrapie are typically initi-
ated by extracerebral exposure to prions, and exhibit early prion
accumulation in germinal centers. Follicular dendritic cells (FDCs),
whose development and maintenance in germinal centers depends
on tumor necrosis factor (TNF) and lymphotoxin (LT) signaling, are
thought to be indispensable for extraneural prion pathogenesis.
Here, we administered prions intraperitoneally to mice deficient
for TNF and LT signaling components. LT/, LT/, LTR/,
and LT/  TNF/ mice resisted infection and contained no
infectivity in spleens and lymph nodes (when present). However,
TNFR1/, TNFR2/, and some TNF/ mice developed scrapie
similarly to wild-type mice. High prion titers were detected in
lymph nodes, but not spleens, of TNFR1/ and TNF/ mice
despite absence of FDCs and germinal centers. Transfer of
TNFR1/ fetal liver cells into lethally irradiated Prnp0/0 mice
restored infectivity mainly in lymph nodes. Prion protein (PrP)
colocalized with a minority of macrophages in tumor necrosis
factor receptor (TNFR) 1/ lymph nodes. Therefore, prion patho-
genesis can be restricted to lymphoreticular subcompartments, and
mature follicular dendritic cells are dispensable for this process.
Macrophage subsets are plausible candidates for lymphoreticular
prion pathogenesis and neuroinvasion in the absence of FDCs, and
may represent a novel target for postexposure prophylaxis.
Prion diseases are lethal, transmissible neurodegenerativeconditions. The causative agent (1) was proposed to be
identical with prion protein Sc (PrPSc), a pathological conformer
of the cellular protein PrPC encoded by the cellular gene Prnp.
PrPC is expressed in many sites, notably including secondary
lymphoid organs. Peripheral inoculation routes are likely to
initiate most forms of spongiform encephalopathies such as
sheep scrapie, bovine spongiform encephalopathy (BSE), iatro-
genic Creutzfeldt–Jakob disease (CJD) and variant CJD (vCJD).
Also, intracerebral (i.c.) or peripheral administration of prions
to mice induces a rise of infectivity in spleen and in other
lymphoid organs long before the development of neurological
symptoms and neuropathological changes. Intraperitoneal inoc-
ulation has been extensively used to study the pathogenesis of
transmissible spongiform encephalopathies because it causes
rapid accumulation of infectivity in secondary lymphoid organs
(2–4). The question of which compartments within lymphore-
ticular tissues support prion replication is of relevance to public
health: contamination with vCJD prions of germinal centers in
lymph nodal and tonsillar follicles, for example, might call for
precautionary measures in handling and sterilization of surgical
instruments.
Tumor necrosis factor (TNF) and lymphotoxin (LT)  signal
through TNF receptor (TNFR) 1, whereas membrane-bound
LT heterotrimers signal through LT receptor (LTR) (5).
TNFR1 and LTR signaling is necessary for development and
maintenance of secondary lymphoid organs (6–10). LTR sig-
naling is also required for maturation and maintenance of
follicular dendritic cells (FDCs), which are thought to be essen-
tial for prion replication and for accumulation of disease-
associated PrPSc within secondary lymphoid organs. Inhibition
of the LT signaling pathway with a soluble receptor, which
depletes FDCs (11), abolishes prion replication in spleens and
prolongs the latency of scrapie after i.p. challenge (12). B
cell-deficient MT mice (13) are resistant to prions i.p. (14),
perhaps because of impaired FDC maturation (12, 15). In
addition to FDCs, PrPC-expressing hematopoietic cells are re-
quired for efficient lymphoreticular prion propagation (16, 17).
Here, we studied peripheral prion pathogenesis in mice lack-
ing TNF, LT, or their receptors. We report that ablation of
LTR signaling prevents all peripheral pathogenesis, whereas
ablation of TNFR1 signaling prevents prion pathogenesis in
spleen but not in lymph nodes, despite the absence of FDCs.
Materials and Methods
Inoculation of Mice. Mice were inoculated i.p. with 100 l of brain
homogenate containing 3–6 log LD50 units of the Rocky Moun-
tain laboratory (RML) scrapie strain (passage 4.1) prepared as
described (18). Mice were monitored every second day, and
scrapie was diagnosed according to standard clinical criteria.
Mice were killed on the day of onset of terminal clinical signs of
scrapie.
Infectivity Bioassays with tga20 Indicator Mice. Assays were done on
1% spleen or lymph node homogenates. Spleens of one individ-
ual mouse, or inguinal, mesenteric, and superficial cervical
lymph nodes pooled from three animals from each experimental
group, were collected. Lymph nodes from every individual
mouse were pooled for the experiments with fetal liver cell
(FLC)-reconstituted chimeric mice. Tissues were homogenized
in PBS5% BSA with a microhomogenizer and passed several
times through 18-gauge and 22-gauge needles. When the sus-
pension appeared homogenous, it was spun for 5 min at 500 
g. Supernatants (30 l) were inoculated i.c. into groups of four
tga20 mice (19). Indicator mice were killed after development of
terminal scrapie; the relationship y  11.45  0.088x (y, log
LD50ml of homogenate; x, incubation time in days to terminal
disease) was used to calculate infectivity titers (20).
Western Blot Analysis. Tissue homogenates were adjusted to 5
mgml (brain) or 8 mgml (spleen) protein and treated with
proteinase K (20 gml, 30 min, 37°C). Fifty micrograms (brain)
or 80 g (spleen) of total protein of each sample were electro-
Abbreviations: FDC, follicular dendritic cell; LT, lymphotoxin; PNA, peanut agglutinin; PrP,
prion protein; TNF, tumor necrosis factor; vCJD, variant Creutzfeldt–Jakob disease; TNFR,
TNF receptor; FLC, fetal liver cell; dpi, days postinfection.
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phoresed through an SDSPAGE gel (12%). Proteins were
transferred to nitrocellulose by semidry blotting. Membranes
were blocked with TBST5% nonfat milk, incubated with
antibodies 6H4 (brain) or 1B3 (spleen), and developed by
Tris-buffered saline  Tween 20 (0.05%)5% nonfat milk
enhanced chemiluminescence (ECL, Amersham Pharmacia) as
described (12).
Immunohistochemistry and Immunofluorescence. Ten-micrometer
frozen sections of spleens or lymph nodes were immunostained
with the follicular dendritic cell marker FDC-M1 (clone 4C11),
CD35 (8C12, PharMingen), peanut agglutinin (PNA), or the
pan-B cell marker anti-CD45ROB220 (RA3-6B2, PharMin-
gen) as previously described (21).
Two-color confocal analysis was performed with antiserum
XN to PrP and ER-TR9, MOMA-1, or F480 on frozen acetone-
fixed tissue sections. For visualization we used secondary FITC-
conjugated F(ab)2 fragments of goat immunoglobulins against
rat (BioSource, Camarillo, CA) and ALEXA 546-conjugated
goat anti-rabbit Ig (Molecular Probes, Leiden, The Nether-
lands). For controls, preimmune sera were used, or, if this option
was unavailable, primary antibodies were omitted.
Construction of Fetal Liver Chimeric Mice. Eight- to ten-week-old
mice were reconstituted with lymphohemopoietic stem cells
(LSCs) derived from fetal livers. Timed pregnancies of wild-type,
TNFR1/ and Prnp0/0 mice served to produce mouse embryos.
Fetal livers were collected at embryonic day 14.5–15.5 in DMEM
and dissociated by using 18-gauge and 22-gauge needles. After
a short spin (15 s, 170 g), the supernatant containing FLCs was
collected and diluted in DMEM. FLCs (5–10  106 cells) were
injected into tail veins of recipients that had been lethally
irradiated (1100 rad) 24 h earlier. Six to seven weeks after
grafting, successful reconstitution was assessed by PCR analysis
of peripheral blood taken from the retroorbital plexus for the
presence or absence of the Prnp or TNFR1 gene locus as
described earlier (17).
Results
After i.c. inoculation, all treated mice developed clinical symp-
toms of scrapie with incubation times similar to those of control
mice (Table 1). In all genotypes, topography and intensity of
spongiosis and gliosis were similar to wild-type mice (not shown),
indicating that TNFLT signaling is irrelevant to cerebral prion
pathogenesis. Upon i.p. prion challenge, wild-type mice showed
an inverse logarithmic correlation between inoculum size (3–6
log LD50) and incubation time (ref. 20; Table 1). Instead, mice
defective in LT signaling proved virtually noninfectible with 5
log LD50 (Table 1). Although these mice occasionally developed
clinical disease when challenged with an extremely large inoc-
ulum (6 log LD50), latency was frequently longer than in
wild-type mice (Table 1). No PrPSc was detected in brains (Fig.
1A) and spleens (Fig. 1C) of clinically healthy LT/, LT/,
LTR/, or LTTNF/ mice 450 days postinfection (dpi),
indicating that defects in the LTLT pathway prevent estab-
lishment of subclinical disease (22).
In contrast, TNFR1/ mice were almost fully susceptible to
all inoculum sizes, albeit with somewhat longer incubation times
than wild-type mice (Table 1). TNF/ mice showed dose-
dependent susceptibility: 67 mice developed scrapie upon
inoculation with 6 log LD50, whereas 27 responded to 3 log LD50
(Table 1). Disease latency in those TNF/ mice that devel-
oped scrapie after 3–4 log LD50 was vastly prolonged (Table 1).
Immunoblot analysis confirmed PrPSc accumulation in brains of
terminally sick TNFR1/ and TNF/ mice (Fig. 1B).
All TNFR2/ mice had intact FDCs and germinal centers
(not shown) and developed scrapie (Table 1), PrPSc accumula- Ta
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tion, and prion infectivity in spleens and lymph nodes (Fig. 1 B
and D) after i.p. challenge with inocula of any size.
Furthermore, all examined TNFR1/, TNFR2/, and
TNF/ mice had all lymph nodes, whereas all LT/,
LTR/, and LT/  TNF/ mice exhibited no lymph
nodes. Twenty-three of 33 LT/ mice had some mesenteric,
but never cervical, lymph nodes. We then determined prion
infectivity over time in spleen and lymph nodes of mice inocu-
lated i.p. (6 log LD50). Infectivity was undetectable in TNFLT-
deficient spleens, with the exception of trace amounts in some
TNFR1/ and TNF/ spleens, and wild-type prion levels in
TNFR2/ spleens (Fig. 1D, blue circles). Accordingly, PrPSc
was undetectable in LT signaling-deficient spleens, and even in
spleens of terminally sick TNFR1/ and TNF/ mice (Fig.
1C). Mesenteric lymph nodes pooled from three LT/ mice at
35, 60, and 90 dpi were devoid of infectivity (Fig. 1D, red
crosses). We found no infectivity in spleens and lymph nodes of
RAG1/ (Fig. 1D) and MT (not shown) mice at 35 dpi, except
for trace amounts of prions in RAG1/ inguinal lymph nodes
(Fig. 1D). Therefore, ablation of mature B cells, the main
suppliers of LT and LT, may result in a phenocopy of genetic
inactivation of LT signaling.
Unexpectedly, all examined lymph nodes (Fig. 1D, red sym-
bols) of TNFR1/ and TNF/ mice had consistently high
infectivity titers across the entire incubation time (35 dpi to
terminal disease). Even inguinal lymph nodes, which are distant
from the injection site and do not drain the peritoneum, con-
tained infectivity titers equal to all other lymph nodes. High
lymph node titers were detected in wild-type mice and even in
TNFR1/ mice exposed to 4 log LD50 (Fig. 1D), suggestive of
active prion replication. We conclude that TNF deficiency
prevents lymphoreticular prion accumulation in spleen but not
in lymph nodes.
Differences in germinal center architecture are unlikely to
account for the differential prion pathogenesis in TNF- and
LT-deficient lymph nodes. Although a thin rim of CD35
marginal zone B cells was present in all analyzed spleens, lymph
nodes and spleens of TNFR1/ and LT/ mice were devoid
of FDC-M1 or CD35 germinal centers, confirming the ab-
sence of mature FDCs. No PNA-positive B cell clusters (indic-
ative of germinal center activation) were detected in lymph
nodes and spleens of TNFR1/ and LT/ mice (Fig. 2).
Next, we generated fetal liver chimeric mice to determine the
cellular subsets and hematopoietic andor stromal components
involved in prion propagation in TNFR1/ lymph nodes (Table
2). FLCs of the TNFR1/, Prnp0/0 or Prnp/ genotypes were
administered intravenously to lethally irradiated recipient mice
(Table 2). Successful reconstitution was assessed by genotyping
peripheral blood cells 6–8 weeks after grafting (data not shown).
We then determined prion infectivity in spleen and lymph nodes
of chimeric mice inoculated i.p. (6 log LD50) 35 days after prion
challenge. In Prnp0/0 mice grafted with TNFR1/ FLCs, high
infectivity loads (3.4–4.2 log LD50) were detectable in lymph
nodes but not in spleens, strongly suggesting that TNFR1/
hematopoietic cells support efficient prion propagation within
lymph nodes. However, lymph nodes of TNFR1/ mice grafted
with Prnp0/0 FLCs also contained substantial amounts of infec-
tivity. Therefore, stromal cells also contribute to the capability
of TNFR1-deficient lymph nodes to replicate prions. Reciprocal
reconstitution of Prnp/ and Prnp0/0 mice showed once again
Fig. 1. Western blot analysis of brains and spleens, as well as determination
of prion infectivity titers in spleens and lymph nodes of scrapie-challenged
TNF- and LT-deficient mice. (A and B) Western blots of brain material electro-
phoresed natively (), or after digestion with proteinase K (PK; ). Large
amounts of PK-resistant prion protein (PrPSc) were detected in the brain of all
mice that had developed scrapie (terminal sick), independently of the geno-
type. Clinical healthy mice deficient in LT signaling showed no PrPSc accumu-
lation, excluding subclinical scrapie (A). (C) Western blots of spleen homoge-
nates electrophoresed natively () or after digestion with proteinase K (PK)
(). TNFR1/ and TNF/ mice accumulated lower amounts of PrPSc as
compared with TNFR2/ and wild-type mice. No PrPSc was detected in the
spleens of clinical healthy LT-deficient mice. (D) Prion infectivity in lymphoid
organs. Titers were determined in spleens (blue circles), inguinal (red circles),
mesenteric (red crosses, x), and cervical (red inverted open triangles) lymph
nodes at the time points indicated below. Mice were inoculated i.p. with 6 log
LD50 or 4 log LD50 of scrapie prions as indicated. Standard deviations within
groups are drawn only when exceeding0.75 log LD50. (a and b) In each of the
two separate transmissions, one of the four tga20 mice died 24 h after
inoculation, most probably because of i.c. bleeding after injection. (j and k)
Intercurrent death during incubation time. Symbols on the abscissa indicate
prion titers below detection limit (none of the four indicator mice developed
scrapie). If one or more indicator mice survived 180 dpi, or the mean
incubation time was over 120 days, titer was assumed to be close to the
detection threshold of the bioassay. For these samples (labeled with small
letters), the numbers of animals succumbing to scrapie of four inoculated
tga20 mice and incubation time (in days in parentheses) to terminal scrapie
were as follows: c, 14 (111); d, 34 (93, 117, 132); e, 24 (90, 95); f, 14 (126);
g, 34 (112, 123, 128); h, 44 (106, 115, 124, 136); i, 34 (89, 102, 119); l, 44 (115,
115, 126, 135); m, 14 (98); n, 24 (74, 78); o, 24 (125, 151); p, 24 (131, 193);
q, 34 (119, 125, 152); r, 24 (109, 117); s, 14 (108); t, 14 (71); u, 34 (80, 96,
98); and v, 24 (98, 98).
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that efficient lymphoreticular prion propagation required PrPC
expression in both stromal and hematopoietic compartments, in
our hands an extremely consistent finding (16, 17).
Two-color immunofluorescence evidenced strong PrP signals
in scrapie-infected TNFR1/ (Fig. 3A) and TNF/ (not
shown) lymph nodes in the absence of germinal centers and
mature FDCs. In wild-type mice, PrP colocalized mainly with
FDC networks, but strong PrP immunoreactivity was also de-
tected in areas devoid of FDC-M1 cells, suggesting that cells
other than FDCs may accumulate PrPSc in lymph nodes (Fig. 3A,
arrowheads). Indeed, PrP colocalized with the macrophage
marker ER-TR9 and MOMA-1 in wild-type lymph nodes (Fig.
3A). No bright PrP signal was detected in secondary lymphoid
tissues of LT/ and Prnp0/0 mice, concordantly with the
finding that these tissues lacked prion infectivity.
What is the nature of the compartment responsible for the
high infectivity of TNFR1/ and TNF/ lymph nodes? The
above results indicate that this compartment does not consist of
mature FDCs, but that both hematopoietic and stromal cells are
involved. Confocal two-color immunofluorescence analysis re-
vealed intense PrP signals colocalizing with F480-, ER-TR9-,
and MOMA-1-positive cells (Fig. 3B) in lymph nodes and, less
frequently, in spleens of TNFR1/ and TNF/ mice. No
colocalization was found with follicular dendritic cell markers
(IDC-M1, FDC-M2, and CD35), T cell markers (CD3, CD4, and
CD8), B cell markers (B220 and CD35), dendritic cell marker
(NLDC-145), natural killer cell marker (Pan-NK), and endo-
thelial cell marker (CD54). As expected, lymphoreticular organs
devoid of prion infectivity (LT/ and Prnp0/0) displayed no
bright PrP immunoreactivity (Fig. 3 A and B).
Discussion
We show here that deletion of TNFR1 or TNF preserves
susceptibility to peripheral prion challenge, whereas deletion of
LT signaling components confers high resistance to peripheral
prion infection. These differential effects on scrapie suscepti-
bility are surprising, because all defects (except TNFR2/)
abolish FDCs, which were thought to be crucial for pathogenesis.
However, LTTNF family members play distinct roles in lymph
Fig. 2. Absence of mature FDCs and germinal center response in spleen and
mesenteric lymph nodes of TNFR1- and LT-deficient mice. Frozen sections of
spleens (three Upper rows) and mesenteric lymph nodes (three Lower rows) at
35 dpi were immunostained with FDC-M1 and CD35 (for FDCs), as well as with
PNA (for activated germinal center B cells). Mature FDCs were detected in
secondary lymphoid organs of wild-type mice but not in those of TNFR1- and
LT-deficient mice, as shown by the lack of FDC-M1 and CD35 staining.
Germinal center B cells were seen only in wild-type mice, as indicated by the
strong PNA immunostaining.
Table 2. Prion load of spleens and lymph nodes in individual FLC-reconstituted chimeric mice
Chimera
Spleen titrations Lymph node titrations
Infectivity (log LD50) Attack rate (mean  SD, days) Infectivity (log LD50) Attack rate (mean  SD, days)
Wild-type3 Prnp0/0 3.5 44 (91  6.6) 3.2 44 (94  10.9)
3.4 44 (93  5.8) 3.7 44 (87  4.7)
3.6 44 (89  5.9) 4.6 44 (78  4.9)
Prnp0/03 wild-type 5.7 44 (66  8.4) 5.1 44 (72  4.7)
4.6 44 (78  4.3) 4.3 44 (82  7.0)
5.7 33 (65  4.0) 4.0 44 (85  12.6)
TNFR1/3 Prnp0/0 1.5 14 (105) 3.7 44 (88  12.9)
1.5 24 (113, 152) 3.4 44 (91  4.4)
1.5 04 3.6 33 (90  6.4)
1.5 04 4.2 44 (81  8.4)
Prnp0/03 TNFR1/ 1.5 14 (85) 4.1 44 (83  4.4)
1.5 04 1.5 24 (65, 67)
1.5 24 (113, 152) 2.8 44 (98  10.7)
1.5 14 (97) 1.5 34 (87, 87, 89)
Wild-type3 wild-type 4.3 44 (81  8.1) 4.1 44 (84  3.5)
4.5 44 (80  1.9) 4.7 33 (76  3.0)
Prnp0/03 Prnp0/0 1.5 04 1.5 04
1.5 04 1.5 14 (137)
TNFR1/3 TNFR1/ 1.5 24 (87, 89) 4.1 44 (83  4.9)
1.5 14 (107) 4.5 44 (79  7.5)
Hematopoietic cells from TNFR1/ mice are able to confer prion replication capability to Prnp0/0 FLCs-reconstituted TNFR1/ mice indicate that a stromal
component plays an additional role in prion propagation. Attack rate, number of indicator mice succumbing to scrapienumber of mice inoculated with prions.
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node induction and development (23): lymphoid organ archi-
tecture, including organization of T and B cell zones, is more
severely impaired in LT- than in TNF-deficient mice (ref. 23 and
data not shown). Because LT and TNF signaling defects may
potentially affect several immune cell lineages, we have per-
formed additional adoptive fetal liver cell transfer studies, which
complement the gene ablation experiments.
The data above imply that prion replication can take place in
secondary lymphoreticular organs even in the absence of mature
FDCs, and that other cells can maintain replication of prions to
titers that are similar to those of wild-type mice. Moreover, prion
pathogenesis in the lymphoreticular system can be topographi-
cally compartmentalized, and lymph nodes (rather than the
spleen) can represent an important reservoir of prion infectivity
during disease.
We then investigated the role of hematopoietic and stromal
cells for peripheral prion pathogenesis in TNFR1/ mice by
using fetal liver chimeras. We found that hematopoietic cells
from TNFR1/ mice restored prion replication in lymph nodes
but not in spleens of Prnp0/0 mice. On the other hand, prion loads
were present also in reciprocal (Prnp0/03 TNFR1/) chimeras,
indicating that immature, non FDC-M1-positive FDC precur-
sors, or other stromal cells might play an additional role in prion
propagation in the lymph nodes of these mice. These findings are
in line with the previous results that PrP-null hosts, recolonized
with PrP-expressing hematopoietic cells, accumulated prions
in lymphoid organs for 200 days after inoculation (16, 17),
and reinforce once again that a hematopoietic component, in
addition to a stromal one, is required for efficient prion
replication in secondary lymphoid organs in this model of
prion pathogenesis.
In addition, we found now that, in the absence of mature
FDCs, the PrP signal colocalized with a subset of single red-pulp,
metallophilic, and marginal-zone macrophages in TNFR1/
lymph nodes. All of the above imply that the cells involved in
prion replication and PrPSc accumulation in the lymph nodes of
TNFR1/ and TNF/ mice are likely to be macrophages, or
some subsets thereof. This hypothesis is strengthened by the fact
that, even in wild-type lymph nodes, bright PrP signals outside
FDC-networks colocalized with a subset of ER-TR9- and
MOMA-1-positive cells (Fig. 3A). TNF signaling through
TNFR1 is required for proper homing of macrophages to the
splenic marginal zone, and their absence can cause strong
aberrations in macrophage subsets. However, MOMA-1 and
ER-TR9 macrophages were normally distributed in the sub-
capsular area of TNFR1/ and TNF/ lymph nodes (ref. 24,
and data not shown), but were strongly disturbed in mesenteric
lymph nodes of LT/ mice. If the distribution of macrophages
is important for peripheral prion pathogenesis, these histoarchi-
tectural differences may account for the differences in splenic vs.
lymph nodal prion load of infected TNFR1/ and TNF/
mice.
Primary and secondary follicles may be functionally different
in spleen vs. mesenteric lymph nodes of TNFR1/ mice (25).
However, we did not identify morphological differences between
splenic and mesenteric germinal centers, and the TNFR1/ line
used here (26) did not show abnormal germinal center responses
after infection with vesicular stomatitis virus (21).
The unexpected finding of high prion titers in inguinal,
mesenteric, and cervical lymph nodes of TNF-deficient mice, but
not in mesenteric lymph nodes of LT-deficient mice, indicates
that prion replication within secondary lymphoid organs is
LTR dependent, yet may occur in the absence of mature FDCs
and of functional germinal centers, as revealed by the lack of
PNA-positive B cell clusters. Therefore, cell types other than
FDCs participate in the process of prion replication
accumulation in lymph nodes and, probably, in spleens. Because
marginal zone macrophages might entertain close contacts to
immature FDCs in the marginal zone, whose presence was
postulated for the TNFR1/ mice (24), and also interact with
marginal zone B cells, this hematopoietic cell type is certainly a
candidate for supportive effects in the process of prion uptake
and replication. There is a caveat to this interpretation: immu-
nofluorescence detects prion protein rather than infectivity, and
does not differentiate unequivocally between PrPC and PrPSc.
Therefore, further studies will need to focus on whether mac-
rophage ablation, e.g., by using macrophage-specific suicide
transgenes, can suppress the infectibility of TNF-deficient lymph
nodes.
These findings are at striking variance with reports that
LT/ mice are fully susceptible to infection with CJD prions
(27), and that TNF/ mice peripherally challenged with ME7
prions were largely protected (28). These and other discrepan-
cies have been attributed to the use of different prion strains in
these studies. This may well be the case, but the present data
indicate that resistance in each mouse strain is dose dependent
and can always be overridden (Table 1). Therefore, challenge
with one single size of inoculum, as done in other studies, may
yield misleading results. Invasion of lymphoid organs by prions
occurs very rapidly after peripheral inoculation, and consistently
high infectivity titers are detected until terminal disease. Lym-
phoinvasion most likely plays an important role in the patho-
genesis of vCJD, because prion infectivity can be detected in
tonsils of virtually every vCJD patient (29, 30). After lympho-
invasion, neuroinvasion occurs via autonomic nerves (31–35),
but the nexus between germinal centers and nerves is still elusive.
By virtue of their mobility, macrophages may represent a plau-
sible candidate for transport of prion infectivity from germinal
centers to sympathetic nerve terminals.
Fig. 3. (A) PrP distribution in mesenteric lymph nodes of scrapie-inoculated
mice by two-color immunofluorescence. Sections were stained with antibody
FDC-M1 to FDCs, ER-TR9, or MOMA-1 to macrophages (green, Upper) and with
antiserum XN to PrP (red, Lower). In wild-type mice, PrP reactivity colocalized
mainly with FDC-networks. Some PrP immunoreactivity was also detected in
areas devoid of FDC-M1-positive cells, which were positive for the macro-
phage stains (arrows). In TNFR1/ lymph nodes, PrP immunoreactivity was
detected in the absence of mature FDCs, as indicated by the lack of FDC-M1
staining. No PrPSc accumulation was detected in secondary lymphoid tissues of
LT/ and Prnp0/0 mice. (B) Two-color immunofluorescence confocal analysis
of secondary lymphoid tissues of TNFR1/, LT/, and wild-type mice. Frozen
sections of spleen and mesenteric lymph nodes (MLN) were stained with
macrophage-specific antibodies F480, ER-TR9, MOMA-1 (green, Top) and
with antiserum XN to PrP (red, Middle). In lymph nodes and, to a lesser extent,
in spleens of TNFR1/mice, immunoreactivity for PrP colocalized with F480-,
MOMA-1-, and ER-TR9-positive cells (yellow-orange color, Bottom). No PrP
signal associated to macrophage subsets was detected in LT/ or in Prnp0/0
lymphoid tissues.
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How could a possible prion amplification in macrophages be
reconciled with their apparent protective role, at least in the very
early phase of prion pathogenesis (36)? Maybe the action of
macrophages is dose dependent: small inocula may be destroyed
by phagocytosis, whereas larger inocula cannot be digested and
will be transported or amplified. Alternatively, the absence of
TNFR1 may interfere directly with the interaction of macro-
phages and prions, because ablation of TNF signaling reduces
the phagocytic ability of macrophages in several infectious
models (37, 38). Be that as it may, the fact that a cell type other
than mature FDCs is involved in prion replication and accumu-
lation within secondary lymphoid organs may help developing
postexposure prophylaxis strategies aimed at blocking prion
neuroinvasion.
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